Vandetanib for thyroid cancer

被引：0
|
作者：
Takahashi, Shunji [1 ]
机构：
[1] JFCR, Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-6-1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Vandetanib—a new therapeutic option in advanced medullary thyroid cancer
    Linda Koch
    Nature Reviews Endocrinology, 2012, 8 (1) : 1 - 1
  • [22] Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer
    Keating, Gillian M.
    Lyseng-Williamson, Katherine A.
    Frampton, James E.
    BIODRUGS, 2012, 26 (06) : 431 - 435
  • [23] Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer
    Bastholt, Lars
    Kreissl, Michael C.
    Fuehrer, Dagmar
    Maia, Ana L.
    Locati, Laura D.
    Maciel, Lea
    Wu, Yi
    Heller, Kevin N.
    Webster, Alan
    Elisei, Rossella
    EUROPEAN THYROID JOURNAL, 2016, 5 (03) : 187 - 194
  • [24] Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
    Deshpande, Hari
    Roman, Sanziana
    Thumar, Jaykumar
    Sosa, Julie Ann
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 213 - 221
  • [25] Combination Therapy of Medullary Thyroid Cancer Using Radiation and Vandetanib
    Sandblom, V.
    Spetz, J.
    Shubbar, E.
    Swanpalmer, J.
    Forssell-Aronsson, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S768 - S768
  • [26] Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer
    Gillian M. Keating
    Katherine A. Lyseng-Williamson
    James E. Frampton
    BioDrugs, 2012, 26 (6) : 431 - 435
  • [27] A PHASE II STUDY OF VANDETANIB IN METASTATIC HEREDITARY MEDULLARY THYROID CANCER
    Paz-Ares, L.
    Haddad, R.
    Krebs, A. D.
    Vasselli, J.
    Robinson, B.
    ANNALS OF ONCOLOGY, 2008, 19 : 247 - 247
  • [28] Efficacy and Safety of Low Dose Vandetanib in Metastatic Medullary Thyroid Cancer
    Modica, R.
    Pizza, G.
    Lo Calzo, F.
    De Cicco, F.
    Sciammarella, C.
    Circelli, L.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2017, 105 : 222 - 222
  • [29] Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response
    Valerio, Laura
    Bottici, Valeria
    Matrone, Antonio
    Piaggi, Paolo
    Viola, David
    Cappagli, Virginia
    Agate, Laura
    Molinaro, Eleonora
    Ciampi, Raffaele
    Tacito, Alessia
    Ramone, Teresa
    Romei, Cristina
    Elisei, Rossella
    ENDOCRINE-RELATED CANCER, 2020, 27 (02) : 97 - 110
  • [30] Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
    Ferrari, Silvia Martina
    Bocci, Guido
    Di Desidero, Teresa
    Ruffilli, Ilaria
    Elia, Giusy
    Ragusa, Francesca
    Fioravanti, Anna
    Orlandi, Paola
    Paparo, Sabrina Rosaria
    Patrizio, Armando
    Piaggi, Simona
    La Motta, Concettina
    Ulisse, Salvatore
    Baldini, Enke
    Materazzi, Gabriele
    Miccoli, Paolo
    Antonelli, Alessandro
    Fallahi, Poupak
    ONCOLOGY REPORTS, 2018, 39 (05) : 2306 - 2314
12345